@article{2e8f5273f3ff42a3b8b8f59ca273ca46,
title = "Anti-CD38 Pretargeted Radioimmunotherapy Eradicates Multiple Myeloma Xenografts In a Murine Model",
author = "Jones, \{Jon C.\} and Hylarides, \{Mark D.\} and Hamlin, \{Donald K.\} and Wilbur, \{D Scott\} and Yukang Lin and Kenoyer, \{Aimee L.\} and Frayo, \{Shani L.\} and Bensinger, \{William I.\} and Gopal, \{Ajay K.\} and Orozco, \{Johnnie J.\} and Gooley, \{Theodore A.\} and Wood, \{Brent L.\} and Pagel, \{John M.\} and Press, \{Oliver W.\}",
note = "Novel therapies, including immunomodulatory agents (thalidomide, lenalidomide and pomalidomide) and proteasome inhibitors (bortezomib, carfilzomib) have improved response rates and prolonged progression free survival for patients with multiple myeloma (MM). Despite these advances the disease remains incurable. MM persistence is presumably due to residual malignant plasma cell clones that evade or develop resistance to available therapies.",
year = "2013",
month = nov,
day = "15",
language = "American English",
volume = "122",
journal = "Blood",
}